NZ514406A - C10 heterosubstituted acetate taxanes as antitumor agents - Google Patents
C10 heterosubstituted acetate taxanes as antitumor agentsInfo
- Publication number
- NZ514406A NZ514406A NZ514406A NZ51440601A NZ514406A NZ 514406 A NZ514406 A NZ 514406A NZ 514406 A NZ514406 A NZ 514406A NZ 51440601 A NZ51440601 A NZ 51440601A NZ 514406 A NZ514406 A NZ 514406A
- Authority
- NZ
- New Zealand
- Prior art keywords
- pyridyl
- taxane
- thienyl
- furyl
- xio
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
- C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Epoxy Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17966900P | 2000-02-02 | 2000-02-02 | |
| PCT/US2001/003553 WO2001056564A1 (en) | 2000-02-02 | 2001-02-02 | C10 heterosubstituted acetate taxanes as antitumor agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ514406A true NZ514406A (en) | 2005-01-28 |
Family
ID=22657495
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ514406A NZ514406A (en) | 2000-02-02 | 2001-02-02 | C10 heterosubstituted acetate taxanes as antitumor agents |
Country Status (21)
| Country | Link |
|---|---|
| US (4) | US6664275B2 (https=) |
| EP (1) | EP1165068B1 (https=) |
| JP (1) | JP2003521514A (https=) |
| KR (1) | KR20020002488A (https=) |
| CN (1) | CN1362876A (https=) |
| AT (1) | ATE381328T1 (https=) |
| AU (1) | AU776767B2 (https=) |
| BR (1) | BR0104350A (https=) |
| CA (1) | CA2368502A1 (https=) |
| CZ (1) | CZ20013523A3 (https=) |
| DE (1) | DE60131927D1 (https=) |
| HK (1) | HK1047896A1 (https=) |
| HU (1) | HUP0200750A3 (https=) |
| IL (1) | IL145639A (https=) |
| MX (1) | MXPA01009924A (https=) |
| NO (1) | NO20014756L (https=) |
| NZ (1) | NZ514406A (https=) |
| PL (1) | PL350027A1 (https=) |
| TW (1) | TWI257390B (https=) |
| WO (1) | WO2001056564A1 (https=) |
| ZA (1) | ZA200108052B (https=) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CZ20013523A3 (cs) * | 2000-02-02 | 2002-03-13 | Florida State University Research Foundation, Inc. | Taxany s C10 heterosubstituovaným acetátem jako protinádorové látky |
| MXPA01009900A (es) * | 2000-02-02 | 2003-08-20 | Univ Florida State Res Found | Formulaciones de taxano que tienen solubilidad mejorada. |
| US7390898B2 (en) * | 2002-08-02 | 2008-06-24 | Immunogen Inc. | Cytotoxic agents containing novel potent taxanes and their therapeutic use |
| CN100522955C (zh) * | 2002-08-02 | 2009-08-05 | 伊缪诺金公司 | 含有新型强效紫杉烷的细胞毒性剂及其治疗用途 |
| CA2539975C (en) | 2003-09-25 | 2012-11-20 | Tapestry Pharmaceuticals, Inc. | 9,10-.alpha.,.alpha.-oh-taxane analogs and methods for production thereof |
| EP1894921A3 (en) * | 2003-09-25 | 2008-03-12 | Tapestry Pharmaceuticals, Inc. | 9, 10-Alpha, Alpha-Oh-Taxane analogs and methods for production thereof |
| CN1712399B (zh) * | 2004-06-24 | 2010-08-11 | 中国医学科学院药物研究所 | 紫杉醇和免疫增强剂胞壁酰二肽共轭物的制备及用途 |
| KR100627436B1 (ko) * | 2005-10-18 | 2006-09-22 | 주식회사 시드컴 | 차량용 요일체킹장치 |
| US11786504B2 (en) | 2006-09-28 | 2023-10-17 | Tapestry Pharmaceuticals, Inc. | Taxane analogs for the treatment of brain cancer |
| WO2008121476A1 (en) | 2007-03-28 | 2008-10-09 | Tapestry Pharmaceuticals, Inc. | Biologically active taxane analogs and methods of treatment by oral administration |
| US11873308B2 (en) | 2006-11-06 | 2024-01-16 | Tapestry Pharmaceuticals, Inc. | Biologically active taxane analogs and methods of treatment by oral administration |
| WO2008109360A1 (en) | 2007-02-28 | 2008-09-12 | Tapestry Pharmaceuticals, Inc | Taxane analogs for the treatment of brain cancer |
| US20080233135A1 (en) * | 2007-03-19 | 2008-09-25 | Gebhard John R | Cobalamin taxane bioconjugates |
| MX2010011165A (es) * | 2008-04-10 | 2011-02-22 | Abraxis Bioscience Llc | Composiciones de derivados de taxano hidrofobos y sus usos. |
| JP2011517683A (ja) * | 2008-04-10 | 2011-06-16 | アブラクシス バイオサイエンス， エルエルシー | 疎水性タキサン誘導体の組成物およびその使用 |
| EP2528687B1 (en) | 2010-01-29 | 2018-08-22 | Micronics, Inc. | System comprising a host instrument and a microfluidic cartridge for assays |
| CN103183724B (zh) | 2010-05-27 | 2015-01-14 | 深圳信立泰药业股份有限公司 | 多西紫杉醇共缀物的制备方法 |
| WO2014100732A1 (en) | 2012-12-21 | 2014-06-26 | Micronics, Inc. | Fluidic circuits and related manufacturing methods |
| CN104919035B (zh) | 2012-12-21 | 2017-08-11 | 精密公司 | 便携式荧光检测系统和微测定盒 |
| EP3549674B1 (en) | 2012-12-21 | 2020-08-12 | PerkinElmer Health Sciences, Inc. | Low elasticity films for microfluidic use |
| JP6472788B2 (ja) | 2013-05-07 | 2019-02-20 | マイクロニクス， インコーポレイテッド | 粘土鉱物およびアルカリ性溶液を使用して核酸含有試料を調製するための方法 |
| EP2994750B1 (en) | 2013-05-07 | 2020-08-12 | PerkinElmer Health Sciences, Inc. | Microfluidic devices and methods for performing serum separation and blood cross-matching |
| JP6484222B2 (ja) | 2013-05-07 | 2019-03-13 | マイクロニクス， インコーポレイテッド | 核酸の調製および分析のためのデバイス |
| EP3516401B1 (en) | 2016-09-19 | 2025-07-30 | Roche Diagnostics GmbH | Instrument for processing cartridge for performing assays in a closed sample preparation and reaction system |
| WO2021252923A1 (en) | 2020-06-12 | 2021-12-16 | Genmark Diagnostics, Inc. | Systems and methods for assessing bays on diagnostic devices |
Family Cites Families (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4960790A (en) | 1989-03-09 | 1990-10-02 | University Of Kansas | Derivatives of taxol, pharmaceutical compositions thereof and methods for the preparation thereof |
| US5175315A (en) | 1989-05-31 | 1992-12-29 | Florida State University | Method for preparation of taxol using β-lactam |
| US5721268A (en) | 1991-09-23 | 1998-02-24 | Florida State University | C7 taxane derivatives and pharmaceutical compositions containing them |
| US5714513A (en) | 1991-09-23 | 1998-02-03 | Florida State University | C10 taxane derivatives and pharmaceutical compositions |
| US5243045A (en) | 1991-09-23 | 1993-09-07 | Florida State University | Certain alkoxy substituted taxanes and pharmaceutical compositions containing them |
| US5283253A (en) | 1991-09-23 | 1994-02-01 | Florida State University | Furyl or thienyl carbonyl substituted taxanes and pharmaceutical compositions containing them |
| US5430160A (en) | 1991-09-23 | 1995-07-04 | Florida State University | Preparation of substituted isoserine esters using β-lactams and metal or ammonium alkoxides |
| SG46582A1 (en) | 1991-09-23 | 1998-02-20 | Univ Florida State | 10-Desacetoxytaxol derivatives |
| US5227400A (en) | 1991-09-23 | 1993-07-13 | Florida State University | Furyl and thienyl substituted taxanes and pharmaceutical compositions containing them |
| PT552041E (pt) | 1992-01-15 | 2000-12-29 | Squibb & Sons Inc | Processo enzimaticos para a resolucao de misturas enantiomericas de compostos uteis como intermediarios para a preparacao de taxanos |
| US5272171A (en) | 1992-02-13 | 1993-12-21 | Bristol-Myers Squibb Company | Phosphonooxy and carbonate derivatives of taxol |
| US5939561A (en) | 1992-03-10 | 1999-08-17 | Rhone-Poulence Rorer S.A. | Process for the preparation of β-phenylisoserine and β-lactam and their analogues |
| US5200534A (en) | 1992-03-13 | 1993-04-06 | University Of Florida | Process for the preparation of taxol and 10-deacetyltaxol |
| FR2702212B1 (fr) | 1993-03-02 | 1995-04-07 | Rhone Poulenc Rorer Sa | Nouveaux taxoïdes, leur préparation et les compositions pharmaceutiques qui les contiennent. |
| US5703247A (en) | 1993-03-11 | 1997-12-30 | Virginia Tech Intellectual Properties, Inc. | 2-Debenzoyl-2-acyl taxol derivatives and methods for making same |
| ES2145829T3 (es) | 1993-06-11 | 2000-07-16 | Upjohn Co | Uso antineoplasico de delta 6,7-taxoles y composiciones farmaceuticas que los contienen. |
| IL109926A (en) | 1993-06-15 | 2000-02-29 | Bristol Myers Squibb Co | Methods for the preparation of taxanes and microorganisms and enzymes utilized therein |
| TW397866B (en) | 1993-07-14 | 2000-07-11 | Bristol Myers Squibb Co | Enzymatic processes for the resolution of enantiomeric mixtures of compounds useful as intermediates in the preparation of taxanes |
| FR2711369B1 (fr) | 1993-10-20 | 1995-11-17 | Rhone Poulenc Rorer Sa | Nouveaux taxoïdes, leur préparation et les compositions qui les contiennent. |
| EP0788493A1 (en) | 1994-10-28 | 1997-08-13 | The Research Foundation Of State University Of New York | Taxoid derivatives, their preparation and their use as antitumor agents |
| MA23823A1 (fr) | 1995-03-27 | 1996-10-01 | Aventis Pharma Sa | Nouveaux taxoides, leur preparation et les compositions qui les contiennent |
| US5780653A (en) | 1995-06-07 | 1998-07-14 | Vivorx Pharmaceuticals, Inc. | Nitrophenyl, 10-deacetylated substituted taxol derivatives as dual functional cytotoxic/radiosensitizers |
| CA2231837A1 (en) | 1995-09-13 | 1997-03-20 | Florida State University | Radiosensitizing taxanes and their pharmaceutical preparations |
| US5714645A (en) * | 1995-10-31 | 1998-02-03 | Kuraray Co., Ltd. | Process for producing all trans-form polyprenols |
| US5756536A (en) * | 1995-11-03 | 1998-05-26 | Purdue Research Foundation | Microbial transformation of taxol and cephalomannine |
| US5899043A (en) * | 1995-12-18 | 1999-05-04 | Engineering Certifiers Ltd. | Ductile-failure anchors for concrete elements |
| US5767297A (en) | 1997-02-05 | 1998-06-16 | Ensuiko Sugar Refining Co., Ltd. | Taxoid derivative and method of producing thereof |
| WO1997042181A1 (en) | 1996-05-06 | 1997-11-13 | Florida State University | 1-deoxy baccatin iii, 1-deoxy taxol and 1-deoxy taxol analogs and method for the preparation thereof |
| CA2259977C (en) | 1996-07-15 | 2005-06-28 | Kabushiki Kaisha Yakult Honsha | Taxane derivatives and drugs containing the same |
| US5811452A (en) | 1997-01-08 | 1998-09-22 | The Research Foundation Of State University Of New York | Taxoid reversal agents for drug-resistance in cancer chemotherapy and pharmaceutical compositions thereof |
| US5912264A (en) | 1997-03-03 | 1999-06-15 | Bristol-Myers Squibb Company | 6-halo-or nitrate-substituted paclitaxels |
| CA2206739C (en) * | 1997-06-03 | 2006-10-10 | Ensuiko Sugar Refining Co., Ltd. | Taxoid derivative and method of producing thereof |
| SE9702776D0 (sv) * | 1997-07-22 | 1997-07-22 | Pharmacia & Upjohn Ab | Method of preparing pharmaceutical compositions |
| US7288665B1 (en) | 1997-08-18 | 2007-10-30 | Florida State University | Process for selective derivatization of taxanes |
| KR20010111580A (ko) | 2000-02-02 | 2001-12-19 | 플로리다 스테이트 유니버시티 리서치 파운데이션, 인크 | 개선된 용해도를 갖는 탁산 제형물 |
| CZ20013523A3 (cs) * | 2000-02-02 | 2002-03-13 | Florida State University Research Foundation, Inc. | Taxany s C10 heterosubstituovaným acetátem jako protinádorové látky |
-
2001
- 2001-02-02 CZ CZ20013523A patent/CZ20013523A3/cs unknown
- 2001-02-02 EP EP01906951A patent/EP1165068B1/en not_active Expired - Lifetime
- 2001-02-02 AT AT01906951T patent/ATE381328T1/de not_active IP Right Cessation
- 2001-02-02 HU HU0200750A patent/HUP0200750A3/hu unknown
- 2001-02-02 KR KR1020017012585A patent/KR20020002488A/ko not_active Abandoned
- 2001-02-02 CN CN01800315A patent/CN1362876A/zh active Pending
- 2001-02-02 NZ NZ514406A patent/NZ514406A/en unknown
- 2001-02-02 WO PCT/US2001/003553 patent/WO2001056564A1/en not_active Ceased
- 2001-02-02 US US09/775,912 patent/US6664275B2/en not_active Expired - Fee Related
- 2001-02-02 CA CA002368502A patent/CA2368502A1/en not_active Abandoned
- 2001-02-02 BR BR0104350-1A patent/BR0104350A/pt not_active IP Right Cessation
- 2001-02-02 HK HK03100167.4A patent/HK1047896A1/zh unknown
- 2001-02-02 AU AU34792/01A patent/AU776767B2/en not_active Ceased
- 2001-02-02 DE DE60131927T patent/DE60131927D1/de not_active Expired - Lifetime
- 2001-02-02 MX MXPA01009924A patent/MXPA01009924A/es active IP Right Grant
- 2001-02-02 IL IL145639A patent/IL145639A/en not_active IP Right Cessation
- 2001-02-02 PL PL01350027A patent/PL350027A1/xx not_active Application Discontinuation
- 2001-02-02 JP JP2001556255A patent/JP2003521514A/ja not_active Withdrawn
- 2001-03-27 TW TW090102213A patent/TWI257390B/zh not_active IP Right Cessation
- 2001-10-01 NO NO20014756A patent/NO20014756L/no not_active Application Discontinuation
- 2001-10-01 ZA ZA200108052A patent/ZA200108052B/en unknown
-
2003
- 2003-06-27 US US10/609,301 patent/US6872837B2/en not_active Expired - Fee Related
-
2005
- 2005-02-28 US US11/068,166 patent/US7157474B2/en not_active Expired - Fee Related
-
2006
- 2006-12-04 US US11/566,439 patent/US20070249707A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| ATE381328T1 (de) | 2008-01-15 |
| AU3479201A (en) | 2001-08-14 |
| DE60131927D1 (de) | 2008-01-31 |
| US6872837B2 (en) | 2005-03-29 |
| EP1165068B1 (en) | 2007-12-19 |
| HUP0200750A2 (hu) | 2002-07-29 |
| US20020068755A1 (en) | 2002-06-06 |
| WO2001056564A1 (en) | 2001-08-09 |
| US20070249707A1 (en) | 2007-10-25 |
| CA2368502A1 (en) | 2001-08-09 |
| ZA200108052B (en) | 2003-12-01 |
| NO20014756D0 (no) | 2001-10-01 |
| JP2003521514A (ja) | 2003-07-15 |
| BR0104350A (pt) | 2002-01-02 |
| US6664275B2 (en) | 2003-12-16 |
| EP1165068A1 (en) | 2002-01-02 |
| MXPA01009924A (es) | 2003-08-01 |
| PL350027A1 (en) | 2002-10-21 |
| KR20020002488A (ko) | 2002-01-09 |
| US7157474B2 (en) | 2007-01-02 |
| AU776767B2 (en) | 2004-09-23 |
| US20040024051A1 (en) | 2004-02-05 |
| HUP0200750A3 (en) | 2005-02-28 |
| US20050143447A1 (en) | 2005-06-30 |
| NO20014756L (no) | 2001-11-29 |
| IL145639A0 (en) | 2002-06-30 |
| HK1047896A1 (zh) | 2003-03-14 |
| CZ20013523A3 (cs) | 2002-03-13 |
| TWI257390B (en) | 2006-07-01 |
| IL145639A (en) | 2007-02-11 |
| CN1362876A (zh) | 2002-08-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6664275B2 (en) | C10 heterosubstituted acetate taxanes | |
| US6673833B2 (en) | C7 heterosubstituted acetate taxanes | |
| US20030114493A1 (en) | C10 carbonate substituted taxanes | |
| US6649632B2 (en) | C10 ester substituted taxanes | |
| CA2368274C (en) | C10 ester substituted taxanes as antitumor agents | |
| US6359154B2 (en) | C7 carbamoyloxy substituted taxanes | |
| WO2001057033A1 (en) | C10 carbamoyloxy substituted taxanes as antitumor agents |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RENW | Renewal (renewal fees accepted) | ||
| PSEA | Patent sealed |